Paid Clinical Trials in Albany, NY
As of September 2026, 171 paid clinical trials are recruiting in Albany, New York. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.
Albany offers studies at sites including Albany Medical Center for conditions such as Non-small Cell Lung Cancer, Obesity, Alzheimer Disease, Acute Myeloid Leukemia. Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Trials by specialty in Albany
Trials by drug in Albany
Filter results
Newly added in Albany
Posted to ClinicalTrials.gov within the last 60 days — these studies are just starting to recruit.
Study of AZD0120 in Newly Diagnosed Multiple Myeloma Ineligible for ASCT
A Study to Investigate Outcomes With Elecoglipron Compared With Placebo in Adult Participants With Chronic Kidney Disease.
A Study to Investigate the Efficacy and Safety of Apraglutide Compared With Placebo in Adult Participants With Short Bowel Syndrome Associated With Intestinal Failure (SBS-IF)
An Open-label Study to Investigate the Efficacy and Safety of Dato-DXd + Rilvegostomig vs SoC in Adult Participants With High-risk MIUC
161 clinical trials
A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
Symbiotic-GU-06: A Study to Learn About PF-08634404 Alone or In Combination With Enfortumab Vedotin in Urothelial Cancer
Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
A Study of Imlunestrant (LY3484356) in Premenopausal Women With Estrogen Receptor-Positive (ER+) Human Epidermal Growth Factor Receptor 2 Negative (HER2-) Early Breast Cancer
Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell Cancer
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a)
OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events
Efficacy and Safety of Ribupatide Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes
Efficacy and Safety of Ribupatide Administered Once Weekly Compared With Semaglutide and Placebo in Participants Living With Obesity Who Do Not Have Diabetes
A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)
Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
Evaluate Optimization of CRS Profile for Glofit Monotherapy and Glofit+GemOx in R/R Aggressive B-NHL
Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells
A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line (1L) Chronic Lymphocytic Leukemia (CLL)/ Small Lymphocytic Lymphoma (SLL) (MK-1026-011/BELLWAVE-011)
Study of LHP588 in Subjects With P. Gingivalis-Positive Alzheimer's Disease
A Clinical Study of MK-2214 in People With Early Alzheimer's Disease (MK-2214-004)
MILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study
Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/Neu Positive Subjects
A Study to Evaluate Zilovertamab Vedotin (MK-2140) Combination With Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in Participants With Previously Untreated DLBCL (MK-2140-010)
A Study of Intismeran Autogene (V940) Plus Pembrolizumab (MK-3475) Versus Placebo Plus Pembrolizumab in Participants With Non-small Cell Lung Cancer (V940-002)
Trial of Nadofaragene Firadenovec vs. Observation in Participants With Intermediate Risk Non-Muscle Invasive Bladder Cancer
A Study to Evaluate Avacopan in Participants With ANCA-associated Vasculitis
Positron Emission Tomography Using 64Cu-SAR-bisPSMA in Participants With High-risk Prostate Cancer Prior to Radical Prostatectomy
Study With Omecamtiv Mecarbil (CK-1827452) to Treat Chronic Heart Failure With Severely Reduced Ejection Fraction
LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-Naïve
Safety and Effectiveness of Left Bundle Branch Area Pacing Versus Conventional Cardiac Resynchronization Therapy in Heart Failure
Ataciguat for Slowing the Progression of Moderate Calcific Aortic Valve Stenosis: A Randomized, Placebo Controlled Study
Registry of Patients With Brain Tumors Treated With STaRT (GammaTiles)
A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease (MINDSET 2)
Global Paradise System US Post Approval Study
Prevalence of Antibodies and Cytokines in Participants With Chronic Granulomatous Disease
A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76)
Top Research Study Locations in Albany
Researchers run research studies in Albany, NY at 25 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| Albany Medical Center | Acute Myeloid Leukemia, B Acute Lymphoblastic Leukemia, Down Syndrome | 61 |
| Albany Medical College | Acute Ischemic Stroke, Acute Stroke, Alzheimer Disease | 20 |
| New York Oncology Hematology, P.C. | Advanced Renal Cell Carcinoma, Advanced or Metastatic Renal Cell Carcinoma, Breast Neoplasms | 10 |
| New York Oncology Hematology | Breast Cancer, Multiple Myeloma, Non-Small Cell Lung Cancer | 9 |
| Capital Cardiology Associates | Aortic Stenosis, Atherosclerotic Cardiovascular Disease (ASCVD), Elevated Lp(a) | 6 |
| Alzheimer's Disease Research Center | Alzheimer Disease, Alzheimer Disease Due to P. Gingivalis, Moderate Alzheimer Disease | 3 |
| 89bio Clinical Study Site | Metabolic Dysfunction-Associated Steatohepatitis (MASH) / Nonalcoholic Steatohepatitis (NASH) With Compensated Cirrhosis, Metabolic Dysfunction-Associated Steatotic Liver Disease (MASH) / Nonalcoholic Steatohepatitis (NASH) With Fibrosis | 2 |
| Kailera Clinical Site | Obesity, Obesity With Diabetes, Overweight With Diabetes | 2 |
| NYOH Albany Cancer Center | Breast Neoplasms, Colonic Diseases, Colorectal Neoplasms | 2 |
| Women's Cancer Care Associates LLC | Endometrial Carcinoma, Endometrial Clear Cell Adenocarcinoma, Endometrial Dedifferentiated Carcinoma | 2 |
| Albany MED Health System | Hematuria - Cause Not Known, Abdominal Distension, Feeding Intolerance | 2 |
| New York Oncology Hematology, P.C. | Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, CLL | 2 |
| ACCOMPLISH-2 Research Site | Chronic Weight Management, Obesity, Overweight | 1 |
| ACCOMPLISH-1 Research Site | Chronic Weight Management, Obesity, Overweight | 1 |
| Albany Med Health System - Washington Avenue Extension | Cardiovascular Diseases, Diabetes Mellitus, Type 2, Hypertension | 1 |
| Albany Medical Center Emergency Department | Pain Management | 1 |
| Albany Medical Center Hospital | Catheterization, Catheterization, Peripheral, Difficult Intravenous Access | 1 |
| Albany Medical College Committee of Research Involving Human Subjects | End Stage Kidney Disease | 1 |
| Albany Medical College, Department of Urology | Prostate Cancer, Prostatic Neoplasms | 1 |
| Albany Medical College- Endocrinology Washington Extension | Hypothyroidism | 1 |
| Albany Stratton VA Medical Center | Breast Cancer, Colon Cancer, Lung Cancer | 1 |
| Alzheimer Disease Research Center (ADRC) | Early Alzheimer's Disease | 1 |
| Anthos Investigative | Atrial Fibrillation (AF) | 1 |
| Capital Cardiology Associates_Albany | Heart Failure, Obesity | 1 |
| Everett Road Surgery Center | Lumbar Spinal Stenosis | 1 |
Active & Upcoming Studies in Albany (2026)
Recruiting trials in Albany grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (62 active studies)
- WATER IV PCa (AS Sub-study) · PROCEPT BioRobotics
- Torvutatug Samrotecan With or Without Bevacizumab as Maintenance Treatment of Platinum-sensitive Relapsed Epithelial Ovarian Cancer · Phase 3 · AstraZeneca
Cardiovascular (17 active studies)
- A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity · Phase 3 · Novo Nordisk A/S
- DRAIN: DRainage in Acute Decompensated Heart faIlure With Pleural effusioNs · Albany Medical College
Neurology & pain (15 active studies)
- Pilot Randomized Control Trial Comparing Oral Ketamine and Oral Oxycodone for Pain Control in Emergency Department Patients · Phase 2, Phase 3 · Albany Medical College
- A Study of Zunveyl on Safety, Tolerability, Neuropsychiatric Symptoms, and Caregiver Distress in Alzheimer's Disease (RESOLVE) · Phase 4 · Alpha Cognition, Inc
Diabetes & metabolic (13 active studies)
- A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2) · Phase 3 · Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure Therapeutics
- Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1) · Phase 3 · Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure Therapeutics
HIV / STI (1 active study)
- A Phase 2b Study Evaluating Oral VH4524184 Regimens in Treatment Naïve Persons With HIV-1 (INNOVATE Study) · Phase 2 · ViiV Healthcare
Mental health & behavior (1 active study)
- Veteran's Perceptions of Ketamine-Assisted Psychotherapy for Depression and End-of-Life · Albany Research Institute, Inc.
Common conditions studied in Albany
- Non-small Cell Lung Cancer (5 active studies)
- Obesity (5 active studies)
- Alzheimer Disease (4 active studies)
- Acute Myeloid Leukemia (3 active studies)
- B Acute Lymphoblastic Leukemia (3 active studies)
- Breast Cancer (3 active studies)
Leading research sponsors in Albany
- Children's Oncology Group
- AstraZeneca
- Albany Medical College
- Merck Sharp & Dohme LLC
- National Cancer Institute (NCI)
Frequently asked questions
How many paid clinical trials are currently recruiting in Albany?
There are approximately 171 recruiting clinical trials in Albany, New York listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Albany pay participants?
Most recruiting trials in Albany compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Albany?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Albany?
The most common conditions under active study in Albany include Non-small Cell Lung Cancer (5), Obesity (5), Alzheimer Disease (4), Acute Myeloid Leukemia (3), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Albany?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Albany on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Albany?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Albany?
Recruiting research sites in Albany include Albany Medical Center, Albany Medical College, New York Oncology Hematology, P.C., among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Albany right now?
The largest active categories in Albany are Cancer & tumors (62), Cardiovascular (17), Neurology & pain (15). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.